Skip to main content
Premium Trial:

Request an Annual Quote

Anthony Caruso, Thomas Klaue

Anthony Caruso has joined Febit as vice president of informatics and application software, the firm said last week. Caruso’s responsibilities include the guidance of the company’s application development and supporting Febit's US customer base.
Prior to joining Febit, Caruso was president and founder of Source Code Genetics, an informatics consulting company focusing on decision support, data mining, and data management. In the past he also held similar positions at Lion Bioscience, Altana Pharma, and Genome Therapeutics.

Thomas Klaue has been named chief financial officer at MediGene, the firm said last week. He will assume his duties effective June 15.
Klaue is currently a partner at Fozzati Partners, a private investment bank in Frankfurt, Germany. He previously served as vice president of business development at Infineon Technologies where he helped establish its biochip business.
Klaue holds degrees in management education from the Massachusetts Institute of Technology and Harvard Business School.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.